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Abstract
Background: Genetic variability is a major feature of human immunodeficiency virus type 1 (HIV-1) and is considered the
key factor frustrating efforts to halt the HIV epidemic. A proper understanding of HIV-1 genomic diversity is a fundamental
prerequisite for proper epidemiology, genetic diagnosis, and successful drugs and vaccines design. Here, we report on the
partial and near full-length genomic (NFLG) variability of HIV-1 isolates from a well-characterized cohort of recently infected
patients in Sa ˜o Paul, Brazil.
Methodology: HIV-1 proviral DNA was extracted from the peripheral blood mononuclear cells of 113 participants. The NFLG
and partial fragments were determined by overlapping nested PCR and direct sequencing. The data were phylogenetically
analyzed.
Results: Of the 113 samples (90.3% male; median age 31 years; 79.6% homosexual men) studied, 77 (68.1%) NFLGs and 32
(29.3%) partial fragments were successfully subtyped. Of the successfully subtyped sequences, 88 (80.7%) were subtype B
sequences, 12 (11%) BF1 recombinants, 3 (2.8%) subtype C sequences, 2 (1.8%) BC recombinants and subclade F1 each, 1
(0.9%) CRF02 AG, and 1 (0.9%) CRF31 BC. Primary drug resistance mutations were observed in 14/101 (13.9%) of samples,
with 5.9% being resistant to protease inhibitors and nucleoside reverse transcriptase inhibitors (NRTI) and 4.9% resistant to
non-NRTIs. Predictions of viral tropism were determined for 86 individuals. X4 or X4 dual or mixed-tropic viruses (X4/DM)
were seen in 26 (30.2%) of subjects. The proportion of X4 viruses in homosexuals was detected in 19/69 (27.5%).
Conclusions: Our results confirm the existence of various HIV-1 subtypes circulating in Sa ˜o Paulo, and indicate that subtype
B account for the majority of infections. Antiretroviral (ARV) drug resistance is relatively common among recently infected
patients. The proportion of X4 viruses in homosexuals was significantly higher than the proportion seen in other study
populations.
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Introduction
Human Immunodeficiency Virus (HIV) has several puzzling
characteristics that separate it from other viruses. The immense
genetic variability of HIV-1, which results mainly from the error-
prone nature of its reverse transcriptase (3610
25 mutations per
nucleotide per replication cycle) [1]. The high rate of mutation
and the rapid turnover of HIV-1 in vivo (10.3610
9 particles per
day) [2] allows for the accumulation and fixation of a variety of
host-immune response selected advantageous genetic changes in
the virus population. These changes allow HIV-1 to resist the
evolving defenses of the host. Recombination is another potential
evolutionary source that significantly contributes to the genetic
diversification of HIV and may produce more virulent viruses,
drug resistant viruses, or viruses with altered cell tropism that may
compromise the effectiveness of antiretroviral therapy and present
major challenges for vaccine design [3].
The striking variability of HIV has led researchers to classify the
virus into four phylogenetic distantly related groups: Main group
(M), Outlier group (O), non-M-non-O group (N) and P group,
which most likely reflect four independent events of cross-species
transmission from chimpanzees [4,5]. The M group, which
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(A–D, F–H, J and K), sub-subtypes (A1, A2, F1 and F2), circu-
lating recombinant forms (CRFs) and unique recombinant
forms (URFs) [4]. The molecular delineation of HIV-1 is a useful
epidemiological instrument for tracking virus transmission and
provides information about the patterns of genetic divergence that
may have occurred during viral evolution.
HIV genetic variants are not geographically confined; however,
there are circulating clades that are predominant in certain areas
[6,7]. For example, in Central Africa the main reported subtype is
A and D, whereas other countries in Europe, USA, Australia and
Thailand have reported subtype B as the main clade associated
with their epidemic. Subtype C viruses are predominant in
South Africa, Ethiopia and India, and CRF01_AE is the major
circulating form in Southeast Asia [8,9,10]. The most prevalent
HIV-1 subtypes in China, Japan’s largest neighbor, are circulating
BC recombinant forms, CRF07_BC, and CRF08_BC, and
account for 50% of the HIV infected population, with subtype B
HIV-1 accounting for 32% [11].
Brazil has the most populous nation in Latin America and the
Caribbean and has the highest number of people living with HIV
in the region (estimates vary from 460.000–810.000; UNAIDS/
WHO. 2010 Report on the Global AIDS Epidemic; 2010). As
in European countries and North America, HIV-1 subtype B
is a major genetic clade circulating in Brazil, but the overall
prevalence of non-B strains, particularly URF BF1, C and URF
BC, has been increasing [12,13,14]. Data from recent studies of
the near full-length genomes (NFLGs) of HIV-1 have provided
evidence of the existence of Brazilian CRF strains designated as
CRF28_BF, CRF29_BF, CRF39_BF, CRF40_BF, CRF46_BF
and CRF31_BC (http://www.hiv.lanl.gov/content/sequence/
HIV/CRFs/CRFs.html.)
Several studies have been conducted to develop and character-
ize panels of well-defined NFLG HIV-1 strains to be used as a
resource in the evaluation of vaccine candidates [15,16,17]. In one
of the largest studies conducted to date, Brown et al. [15] reported
the complete genetic and biological characterization of a panel of
60 full-length sequenced HIV-1 isolates from 15 countries,
including R5 and X4 viruses, representing clades A through D
and CRF01_AE.
The present study involved the phylogenetic analysis of HIV-1
partial and NFLGs, the evaluation of HIV drug resistance and the
evaluation of viral co-receptor tropism in treatment-naı ¨ve recently
infected individuals from Sa ˜o Paulo, one of the main cities in Brazil.
Materials and Methods
Study population
One hundred and thirteen participants were selected from a
larger cohort of 228 recently HIV-1 infected persons by order of
entrance into the study. This sub-cohort was part of an ongoing
project to investigate the host factors that contribute to
immunodeficiency progression and has been previously described
[18]. Briefly, recent HIV-1 infection was determined by the
Serologic Testing Algorithm for Recent HIV Seroconversion
(STARHS), and individuals were included in the study when they
had a negative desensitized ELISA HIV-1 test, as that could
indicate an incomplete antibody response as a consequence of
recent HIV infection. For this study, patient PBMC samples were
collected using standard procedures during their first clinical visit
before the beginning of therapy and stored at 280uC until use.
The patient data, including age, sexual orientation, number of
CD4-positive T cells, and viral load were obtained from medical
records. All study participants signed an informed consent form
and the project was approved by the ethics committee of the
federal University of Sa ˜o Paulo.
Amplification and sequencing of HIV-1 DNA
ThegenomicDNAusedforthePCRanalyseswasextractedfrom
buffy coat samples with a QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany), according to the manufacturer’s instructions.
Proviral DNA was used as the PCR template, as this allowed
amplification of the NFLGs from five overlapping fragments as
previously described [12,13]. All amplification reactions were done
in duplicate to eliminate PCR artifacts such as a sequenced NFLG
being assembled from heterogeneous DNA targets. The amplified
fragments were purified by use of a QIAquick PCR Purification Kit
(Qiagen, Hilden, Germany) and directly sequenced on both strands
usingavarietyofprimer-directedstrategiesand the PRISMBigDye
Terminator Cycle Sequencing Ready Reaction Kit (Applied
Biosystems/Perkin-Elmer, Foster City, CA) on an automated
sequencer (ABI 3130, Applied Biosystems). After excluding the
primer regions, the fragments for each amplicon were assembled
into contiguous sequences and edited with the Sequencher program
4.7 (Gene Code Corp., Ann Arbor, MI).
Screening for recombination events and identification of
breakpoints
All sequences were screened for the presence of recombination
events via the genotyping function of NCBI (NCBI Blast genotyping
tool. Available at: http://www.ncbi.nih.gov/projects/genotyping/
formpage.cgi) and the jumping profile Hidden Markov Model
(jpHMM) [19]. Recombination events were further confirmed by
the bootscanning method [20] implemented in SimPlot v. 3.5.1 for
Windows [21] using the following parameters: window size 250 bp,
step size 20 bp and the F84 model of evolution (Maximum
likelihood) as a model to estimate nucleotide substitution, the
transition\transversion ratio of 2.0, and a bootstrap of 100 trees.
The significance threshold for the bootscan was set at 70%. The
alignment of multiple sequences, including reference sequences
representing subtypes A–D, F–H, J and K (http://hiv-web.lanl.
gov), were performed using the CLUSTAL X program [22] and
then followedbymanualeditinginthe BioEdit SequenceAlignment
Editor program [23]. Gaps and ambiguous positions were removed
from the final alignment. The positions of crossover sites were
preliminarilydefinedbased onthedistribution ofinformative sites, a
method implemented in SimPlot v. 3.5.1, supporting the two
incongruent topologies which maximize the x
2 value [24].
Phylogenetic tree analysis
All phylogenetic trees were estimated by use of a general time
reversible model under maximum likelihood (ML) using PHYML
v.2.4.4 [25]. Heuristic tree searches using the ML optimality
criterion were created using the nearest-neighbor interchange
(NNI) branch-swapping algorithm. The approximate likelihood
ratio test (aLRT) based on a Shimodaira-Hasegawa-like procedure
was used as a statistical test to calculate branch support. All trees
were displayed using either the MEGA v.5 package or the freely
available Archaeopteryx Java software [26]. Nucleotide similarities
were estimated using a maximum composite likelihood model
implemented in MEGA version 5.0 software. The comparisons of
tree topologies of the subtype B subgenomic regions were
performed using an algorithm described by Nye et al. [27].
Genotypic tropism analysis
For the predictions of HIV tropism, the env region identified in
the NFLGs and partial-length env sequences that would encompass
Analysis of HIV-1 Strains in Sa ˜o Paulo, Brazil
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implemented as the web-based service geno2pheno [coreceptor]
http://www.geno2pheno.org. To minimize the number of false
predictions of CXC chemokine receptor 4 (CXCR4 or X4) tropic
sequences as C–C chemokine receptor 5 (CCR5 or R5) tropic, a
conservative false-positive rate (FPR) of 20% was used as a cutoff.
Therefore, X4 or X4 dual/mixed-tropic viruses (X4/DM) were
reported positive if their sequences had a prediction result FPR
of#20% or the 11/25 rule predicted a X4 virus, otherwise, they
were considered R5-tropic viruses.
Determination of drug-resistance mutations
The proviral nucleotide sequences of the pol region were
translated into amino acid sequences and subsequently screened
for drug-resistance mutations using the most updated WHO list
for the surveillance of drug resistance mutations in antiretroviral-
naive patients (SDRM version 2009, http://hivdb.stanford.edu/
pages/WHOResistanceList.html).
All nucleotide sequences obtained during our study were
reported to GenBank (Accession numbers pending).
Results
Samples
In total, 113 blood samples from recently HIV-1 infected
individuals were subjected to NFLG sequencing. The median
baseline HIV-1 viral load of 108 samples was 1.5610
4 copies/ml
(range,,39927610
5). The median baseline CD4 cell count
was,560 cells/mm3 (range, 83–2449 cells/mm3) in 98.2% of
individuals. The participants’ ages ranged between 18 and 56
years, and the median age was 31 years. The majority of subjects
were males (n=102; 90.3%) and a sizable proportion (n=90;
79.6%) reported transmission through homosexual contact. All
patients were treatment-naive at the time of sample collection. The
main characteristics of the study population are given in Table 1.
Virus variants with stop codons in different open reading frames
were identified in five samples. A gross deletion of 433 (Nucleotide
position from start of HXB2 genome; 5464–5896) and 487 bp
(Nucleotide position from start of HXB2 genome; 1337–1823)
were observed in isolate 04BR 1071 (characterized as subclade F1)
and 04BR 1074 (characterized as subtype B), respectively. A
sequence duplication of 322 bp (Nucleotide position from start of
HXB2 genome; 8512–8826) was observed in isolate 03BR 2015
(characterized as subtype B). We are currently assessing the
accuracy of the large deletions and insertions in the aforemen-
tioned RNA isolates via ultra-deep 454 pyrosequencing. None of
these sequences, including those with stop codons, were omitted
from the analysis.
HIV variants and sequences
Sequences were obtained for all five overlapped fragments that
cover the NFLGs of 77 participants. Partial sequences were
obtained from at least one fragment derived from 32 samples as
shown in Table 2. Only four samples did not amplify for any
fragment. The amplification failure in these samples was likely not
be due to subtype diversity, as our method is effective for the
analysis of diverse HIV-1 strains.
The distribution of HIV-1 subtypes by NFLG
The phylogenetic analysis of the 77 HIV-1 incident samples with
NFLG sequences revealed 64 pure subtypes (83.1%) and 13
recombinants subtypes (15.1%). A comparison of the NFLG
sequences from 64 pure subtypes is presented in Figure 1. With
the exception of isolates 04BR 2022 and 04BR 1071, which cluster
with high aLRT values within the reference isolate clusters for
subtype C and subclade F1, respectively, all samples clustered with
subtype B. This group contains sequences from both MSM (n=57)
and heterosexual individuals (n=7; 5 males and 2 females). In the
topological phylogenetic tree of NFLG pure subtype B depicted in
Figure 1; various samples are positioned in various well-defined
clusters supported by high aLRT values. The stability and order of
these clusters werefurther investigatedwith ML trees independently
made with the gag-pol and env sequences using the same multiple
genome alignment (Figures 2a&2b). The phylogenetic trees from
both regions received an overall topological score of 63.8% as
scored by the Nye et al. algorithm [27]. Close examination of both
subgenomic trees revealed a shifting of topological position across
numerous sequences in a manner suggestive of intra-subtype
recombination [28]. For example, isolates 04BR 1060 and 04BR
1068 changed their topological positions over the gag-pol and env
regions of their genomes. The computed topological score of the
isolates in both regions was 33.3%, with a branch length mismatch
of 89.5%. Similarly, isolate 05BR 1089 placed the gag-pol region
with 05BR 1103 with an 100% of aLRT value, while env strongly
grouped (aLRT,94%) with isolate 05BR 1081 (Figures 2a&2b).
The evolutionary relationship between the representative subtype
sequences was analyzed to illustratethe level of genetic diversity and
to identify cross epidemic relationships that could suggest common
geographic origins of subtype B present among presumably
circulating subtype B viruses in Sa ˜o Paulo. The resulting 62 pure
subtype B sequences were compared with each other and with 435
non-redundant B sequences (unique patient entries) available in the
Los Alamos database and collected from more than 30 countries
including Brazil (Figure 3a). The ML tree showed that sequences
from Brazil appeared dispersed, even if a subcluster of Brazilian
sequences was observed (Figure 3a; green nodes). This subcluster
Table 1. Characteristics and main findings of the Brazilian
HIV-1 recently infected individuals.
Male gender 102 (90.3%)
Media age (Years) 31
Risk group (n=113)
homosexual men 90 (79.6%)
heterosexuals 23 (20.4%)
Median CD4 count (cells/mm3) 560
Median viral load (log HIV RNA copies/mL) (n=108) 15000
Drug resistance mutations (n=101) 14 (13.9%)
PI 6 (5.9%)
NRTI 6 (5.9%)
NNRTI 5 (4.9%)
Subtype distributions (n=109)
B 88 (80.7%)
BF1 12 (11%)
C 3 (2.8%)
BC 2 (1.8%)
F1 2 (1.8%)
CRF31 BC 1 (0.9%)
CRF2 AG 1 (0.9%)
Prediction of viral tropism (n=86)
X4 viral tropism (pure or dual/mixed R5/X4) 26 (30.2%)
doi:10.1371/journal.pone.0025869.t001
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non-recombinant clade B HIV-1 identified in this study. Further
analysis of the subcluster indicated that some strains grouped with
high aLRT (.98%) values with little genetic diversity (branch
length,0.015) into various main transmission clusters composed
of 2 to 3 infections per cluster within the B molecular subtype
(Figure 3b). Notably, three sequences obtained from heterosexual
contact-acquired infected patients (Figure 3b; brown square) are
tightly positioned within some of the MSM risk groups. As shown in
Figure 3A,the sequencesidentifiedin this study and otherpublished
Brazilian clade B sequences have a close genetic relationship with
those previously found in the United States.
Characterization of the NFLG recombinant sequences
Among the 13 NFLG isolates with strong evidence of recombina-
tion, 10 were mosaic isolates consisting of subtype BF1, 2 of subtype
BC and 1 identified as CRF02 AG. None of the putative BF1
recombinants had a recombination profile identical to the other BF
mosaics described in Brazil or elsewhere (Figure 4). Moreover, there
was no obvious preferred location for breakpoints. To further test for
recombination, ML phylogenetic trees were generated for the
nucleotide sequence regions on either side of the breakpoints detected
by the bootscan method (Figure 5). This analysis corroborates the
results from the bootscan and thus provides unambiguous evidence for
recombination events supported by high aLRT values. The nucleotide
sequence of isolate 06BR 2039, characterized as CRF02 AG, was
blasted against the NCBI nucleotide database. A significant number of
similar full genome hit with a Nigerian HIV-1IbNg (GenBank:
L39106) strain was indicated by the search.
The distribution of HIV-1 subtypes by partial sequencing
The overall proportion of subtypes and recombinants generated
by partial sequences is shown in Table 2. Consistent with the
results obtained from the NFLGs analysis, the phylogenetic tree
Table 2. HIV-1 strain subtyping by partial sequences.
Sample ID Sequence fragment Subtype
A (546–2598) B1 (2157–3791) B2 (3236–5220) C (4890–7808) D (7719–9537)
03BR 1025 ++ 2 ++B
03BR 1032 22 2 + 2 B
03BR 1034 + 222 2 B
03BR 1037 + 2 + 22C
03BR 1042 ++ + 2 + B
04BR 1050 ++ 2 ++B
04BR 1056 2 +++ + B
04BR 1058 2 + 22 2 B
04BR 1059 + 2 + 22B
04BR 1062 ++ 2 + 2 BF1
04BR 1063 2 222 + B
04BR 1069 ++ 22 + B
05BR 1073 + 2 ++ + B
05BR 1086 ++ 22 2 B
05BR 1087 ++ + 22B
05BR 1088 2 +++ + B
05BR 1091 ++ 2 + 2 F1
05BR 1096 ++ + 2 + B
05BR 1099 2 + 22 + B
05BR 1102 ++ 22 + C
05BR 1105 ++ + 2 + B
05BR 1106 ++ + 2 + B
06BR 1113 ++ + 2 + B
06BR 1116 2 + 22 2 CRF31 BC
06BR 1118 2 ++2 + BF1
06BR 1122 ++ + 22B
06BR 1123 ++ 2 ++B
03BR 2010 ++ + 2 + B
03BR 2013 2 ++22B
04BR 2024 2 ++22B
04BR 2030 ++ + 22B
05BR 2037 + 2 + 22B
doi:10.1371/journal.pone.0025869.t002
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subtypes B strains (79%). Subtypes C and BF1 were detected in
four samples (6% each). Subtype F1 and a CRF31 BC variant
were isolated in one sample (3% each).
ARV drug resistance-associated mutations
The HIV-1 proteaseand RT regions of viruses obtained from 101
patients were scrutinized for any ARV drug resistance-associated
mutations. Primary drug resistance mutations were detected in 14
patients (13.7%). Of these, 12 (85.7%) patients were infected with
subtype B HIV-1. The distributions of these mutations by drug class
were as follows: five patients had resistance to protease inhibitors
(PIs), three patients to non-nucleoside RT inhibitors (NNRTI), three
patients to nucleoside RT inhibitors (NRTI), one patient to
PI+NNRTI, and two patients to NRTI+NNRTI (Table 3).
V3 sequence analysis and viral tropism
An evaluation of the V3 loop amino acids and predictions of
viral tropism were performed for 86 of the derived NFLG and
partial sequences. Using the computer program geno2pheno [co
receptor] for phenotype prediction, 26 patient virus strains (30.2%)
were predicted to be X4 or X4/DM, and the V3 sequences of 60
patient virus strains (69.8%) were predicted to be R5-tropic virus.
Among the MSM group evaluated for co-receptor tropism (n=69),
19(27.5%) patient virus strains were predicted to be X4 or X4/
DM and three patient samples have viruses with evidence of
resistance to at least one ARV drug (Table 3). The tetrapeptide
GWGR, a motif frequently detected in Brazilian subtype B
sequences, in the V3 loop apex sequence was observed in 17
(19.8%) patients. Of these patients, 6 (25%) had a predicted X4 or
X4/DM virus. The N-linked glycosylation sites (amino acids 4
to 6; positions 305 to 307 in HXB2 Env), essential for viral
replication and the heptapeptide DIIGDIR (amino acids 32 to 38;
positions 322 to 327 in HXB2 Env) were completely conserved in
64 and 19 subjects, respectively (data not shown).
Discussion
In the present study, 77 NFLG and 32 partial sequences from
recently HIV-1 infected Brazilian subjects were analyzed. The
phylogenetic analysis of the sequences presented here showed that
subtype B is largely dominant (79.8%), followed by BF1 URF.
Figure 1. Phylogenetic tree constructed using a maximum-likelihood method from the NFLG sequences of 64 patient samples and
37 HIV-1 reference sequences from the Los Alamos HIV-1 database representing 11 genetic subtypes. Annotation of samples is as
follows: symbol-green circle (subtype B), symbol-blue square (subtype C), symbol-red triangle (subclade F1), symbol-brown square-M indicates
heterosexual male, symbol-brown square-F indicates heterosexual female, and symbol-black square indicates homosexual male. The approximate
likelihood ratio test (aLRT) values of$90% are indicated. The scale bar represents 0.05 nucleotide substitutions per site.
doi:10.1371/journal.pone.0025869.g001
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subtype B and BF1 URF variants in Sa ˜o Paulo particularly among
MSM, which are the most represented group in our study.
Subtype C, F1, CRF31 BC and CRF02_AG were detected in
small proportions. Overall, these data demonstrate a mature
heterogeneous epidemic, which is consistent with the results of
previous epidemiological studies in Brazil [29,30,31,32,33,34]. In
the phylogenetic analysis of NFLGs, there was evidence of various
clusters of non-recombinant subtype B sequences. The majority of
clustered subtype B isolates were closely related to the reference
strains from United States. These results indicate that HIV
infection in Sa ˜o Paulo is likely a result of direct transmission of a
clade B virus from the United States, possibly via the heavy traffic
of young Brazilian men in search of income opportunities in the
United States.
The occurrence of intra-subtype recombination among non-
recombinant subtype B isolates and the detection of the mixed BF1
and BC recombinants indicate that subtype B HIV-1 is not only
the predominantly circulating subtype in the Brazilian HIV
infected population, but the viral strains are also evolving and
diverging into new strains over time. In addition, our analysis
demonstrates that the heterogeneity within the global B subtype is
equally reflected within the Brazilian subtype B viruses. Previous
studies aimed at reconstructing the past population dynamics of
subtype B in Brazil via the coalescent theory have indicated that
the epidemic growth of this clade started in the late 1960 s, where
it grew exponentially over the first 2 decades [35]. The element
that initially contributed to and fueled the exponential growth of
subtype B viruses may have been primarily be the transmission
from acutely infected MSM and IDU [36,37].
The proportion of recombinant strains in the state of Sa ˜o Paulo
was defined from NFLGs and partial sequences. Sixteen
recombinant variants have been found, in which two isolates
06BR 2039 and 06BR 1116 displayed a recombinant structure
identical to CRF02 AG and CRF31 BC, respectively. These
results indicate that at least 14% of the strains circulating in Sa ˜o
Figure 2. Maximum likelihood tree of sequences identified in this study (indicated by black circles) and reference strains inferred
from full-length gagpol (A) and env (B) nucleotide sequences. For clarity purposes, the tree was midpoint rooted. The approximate likelihood
ratio test (aLRT) values of$90% are indicated at nodes. The scale bar represents 0.05 nucleotide substitutions per site.
doi:10.1371/journal.pone.0025869.g002
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highlighted in other studies in Sa ˜o Paulo [38].
In Brazil, on a regional scale, most infections in the frontier
municipalities in the southern region of the country are caused by
subtype C and BC recombinants, including CRF31 BC
[12,39,40], which are also circulating as minor strains in the
country’s southeast and central west [32,41]. Consistent with the
results of these previous studies, our analysis also showed a lack of
the substantial spread of subtype C and its recombinants in our
cohort. It is possible that the high prevalence of subtype B viruses
and other recombinant variants saturating the HIV-infected
population coupled with effective behavior changes may be
responsible for the differential spread of these strains. It is also
possible that the bias created by the inclusion of predominantly
MSM in our cohort affected the observed differences, and
therefore, it may not reflect the HIV dynamics of the general
population.
In agreement with the results of our previous study [42], the
proportion of subclade F1 viruses examined in the present study
was considerably lower than the previous estimates inferred from
partial sequences. In fact, most HIV-1 subclade F1 strains
circulating in Brazil may have contained recombinant genomes,
particularly with subtype B as indicated in the present study and
other studies [13,43]. These recombinant genomes could have
gone unrecognized by partial sequencing.
Our results indicate that prevalence of mutations conferring
ARV resistance in recently infected patients is common (13.7%). It
is possible that these resistant mutations may translate into lower
rates of treatment response and higher rates of treatment failure.
Some patients carrying multiple resistance mutations who fail
ARV therapy have been shown to be infected with X4 viruses
possessing a high replication capacity [44]. However, these
observations could not be confirmed in other studies [45,46].
The frequency of X4 and D/M tropism in the present study was
30.2%, a rate slightly higher than those found in a recent studies of
HIV seroconverters [47] and drug-naive, chronically HIV-infected
individuals [48,49]. The high rate of X4 and D/M tropism seen in
this study may be explained at least partly by the fact that most of
the samples in this study were derived from MSM individuals. It is
noteworthy that the prevalence of X4 and D/M tropism among
Figure 3. Phylogenetic relationships among subtype B HIV-1 NFLG sequences sampled from different countries. (a) Midpoint-rooted
maximum-likelihood tree of 435 HIV-1 non recombinant subtype B NFLG sequences sampled from various global locations (colored branch). In
addtion to previously published Brazilian subtype B NFLGs and other South American sequences from neighboring countries. The tree also contains
62 isolates sampled in Sa ˜o Paulo from HIV-1 recently infected patients over a 4- year period between 2002–2006 (the present datasets). (b) For clarity,
the Brazilian isolates branched as a monophyletic cluster was displayed. Annotation of samples is as follows: symbol-brown square-F indicates
heterosexual female, and symbol-black square indicates homosexual male. The approximate likelihood ratio test (aLRT) values of$70% are indicated.
The scale bar represents 0.01 nucleotide substitutions per site.
doi:10.1371/journal.pone.0025869.g003
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study of 126 recently infected MSM from six major cities in the
USA [50]. This high prevalence should seriously be considered
when decisions are made about initial regimens for therapy-naive
individuals, and HIV-1 coreceptor usage should be screened
before initiation of any chemokine receptor CCR5 antagonists in
clinical settings. These suggestions are in agreement with the
conclusions of Frange et al. [51] that noted that X4/DM strains
can heavily fuel the cellular HIV-1 reservoir leading to viral
persistence over a long period complicating future therapeutic
options, including CCR5 antagonists.
The assessment of HIV tropism in our study was limited to
sequence- based algorithms rather than using phenotypic methods.
Although phenotypic assays still have an edge over genotypic
methods, genotypic predictors prove to be highly concordant with
phenotype data and can reliably be used to determine viral
tropism with better results in PBMC than in plasma samples [52].
In this study, we used geno2pheno because it allows for an
Figure 4. Schematic representation of the NFLG structure and breakpoint profiles of the BF1 sequences identified in this study and
other BF1 URF and CRF published sequences. Sequences marked with the symbol (*) were originally classified as pure subtype but were
characterized in the current analysis as pure B subtype, thus suggesting that a revised classification of these isolates in the GenBank and the HIV
databases is appropriate. The region of subclade F1 and subtypes B are indicated at the bottom.
doi:10.1371/journal.pone.0025869.g004
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Annotation of samples is as follows: symbol-green circle (subtype B), symbol-blue square (subtype C). The approximate likelihood ratio test (aLRT)
values of$90% are indicated at nodes. The scale bar represents 0.01 nucleotide substitutions per site. The region of subtype C, subtypes B, and
subclade F1 are indicated at the bottom.
doi:10.1371/journal.pone.0025869.g005
Table 3. Drug-resistance mutations detected in antiretroviral (ARV) naı ¨ve patients.
Sample ID Resistance mutations HIV-1 subtype Tropism Risk
PI NRTI NNRTI
04BR 1050 L24I,M46I,F53L, I54V, V82S M41L, D67N, T215Y B X4 MSM
06BR 1123 D30N, M46I B R5 MSM
05BR 1105 D30N, M46I B ND MSM
04BR 1055 D30N B R5 MSM
03BR 1020 G73S B R5 MSM
05BR 1077 V82A B R5 MSM
05BR 1088 V75A B X4 HET
M*
05BR 1075 M184V K103N B R5 MSM
05BR 1107 M184I B R5 MSM
03BR 1042 M184I B ND MSM
03BR 2018 M184V K103N BF1 R5 HET
M
04BR 1053 K103N B X4 MSM
04BR 1067 K103N BF1 R5 HET
M
05BR 1111 K103N B X4 MSM
*HET
M; heterosexual man, MSM; men who have sex with men.
doi:10.1371/journal.pone.0025869.t003
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all viral genotypes. This method has shown a similar performance
to the Trofile phenotypic assay, the most often used tropism
method [53]. Moreover, the method has been shown to achieve
higher sensitivity while retaining high level of specificity when
compared with the performance of different algorithms [54,55].
Our study represents the largest analysis of the NFLG of the
HIV-1 genomes undertaken to date from well-characterized
recently infected patients and provides recent data on the
molecular characterization of HIV-1 in treatment-naı ¨ve patients
residing in Sa ˜o Paulo, Brazil. Overall, our results demonstrate a
cocirculation of 3 group M viral subtypes (B, C, and F1), 3 URFs
(BF1and BC), and 2 CRFs (CRF2 AG and CRF31 BC). However,
these data need to be interpreted with some caution, as the
samples recruited may not fully represent the general population
of Sa ˜o Paulo because they disproportionately represent men who
reported having sex with men.
The existence of various HIV-1 subtypes in Brazil will
invariably challenge existing diagnostic tests and/or interpretation
algorithms. Depending on future findings related to the transmis-
sibility, pathogenicity, and treatment implications of various
subtypes, these variant subtypes may also play a role in changing
the nature of the HIV epidemic in Brazil. Thus, it is therefore to
increase strain surveillance across Brazil. The identification and
characterization of HIV-1 subtypes will strongly impact our
understanding of the epidemic and the necessary approaches to
ameliorate the epidemic. In conclusion, the present study
addresses the need, in the design and implementation of vaccines
and ARV therapy programs, for the identification of the concrete
proportion of infections caused by different HIV-1 subtypes.
Moreover, our data affirm that any new vaccines that will be
pursued through clinical trials should take into consideration the
multiple subtypes of HIV-1.
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